I mercati dell'Italia hanno chiuso

ZNTL Oct 2024 30.000 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
0,05000,0000 (0,00%)
Alla chiusura: 09:58AM EDT
Schermo intero
Chiusura precedente0,0500
Aperto0,0500
Denaro0,0000
Domanda0,7500
Prezzo d'esercizio30,00
Scadenza2024-10-18
Min-Max giorno0,0300 - 0,0500
Contratto - Min-MaxN/D
Volume1
Open Interest5
  • GlobeNewswire

    Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    NEW YORK and SAN DIEGO, Oct. 02, 2023 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company discovering and developing clinically differentiated small molecule therapeutics targeting fundamental biological pathways of cancer, today announced that on October 2, 2023, the Compensation Committee of Zentalis’ Board of Directors granted non-qualified stock options to purchase an aggregate of 101,375 shares of the Company’s common stock to four